Clarity Engagement Solutions Appoints Kevin Simpson as CEO

Clarity Engagement Solutions, a leading provider of performance consulting, training and execution in the life sciences, medical device and corporate & institutional banking industries announces the appointment of Kevin Simpson as its CEO.. He assumes day-to-day leadership of the company besides joining Clarity's Board of Directors with effect from 18, November. Most recently, he has served as the company’s CLO, leading the account engagement transformation initiatives with multiple clients, as well as developing and expanding the firm’s spaced learning platform and capabilities. Mr. Simpson will succeed Chris Deren, who will remain with Clarity as Chairman and Founder.

Commenting on this appointment, Chris Deren, chairman & founder of Clarity, says, “To have Kevin who is both a life sciences industry veteran and a champion of customer engagement innovation lead Clarity to its next stage of growth is a real win for both the company and our customers.” He adds, "It's also a real dose of validation for Clarity and its vision as Kevin was previously a Clarity client at Novartis and Teva."

"I am incredibly excited about the opportunity to lead

To have Kevin who is both a life sciences industry veteran and a champion of customer engagement innovation lead Clarity to its next stage of growth is a real win for both the company and our customers

Clarity through its next stage of growth and innovation.

Our clients' customer ecosystems change relentlessly, while Clarity and our continually evolving solutions are uniquely positioned to drive success in this environment," reveals Kevin simpson, CEO, Clarity. "During the course of my career, and as a Clarity customer on multiple occasions, I have personally experienced the transformative effect the company and its offerings have, worldwide. This is why I am passionately engaged in our future," he adjoins.

Clarity develops fully customized, end-to-end solutions to help companies develop their customer-facing field teams and make the shift from transactional selling to strategic account management. Since 2009, the company has helped some of the largest and most successful pharmaceutical companies tailor the four zones of customer engagement to specific account segments and customer environments in more than 30 countries around the world. With the immense experience and expertise he brings to the table, Simpson is sure to make further significant contributions towards the future prospects of the company.